These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4627506)

  • 1. Intravaginal immunization of humans with Candida albicans.
    Waldman RH; Cruz JM; Rowe DS
    J Immunol; 1972 Oct; 109(4):662-4. PubMed ID: 4627506
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to Candida albicans in human cervicovaginal secretions.
    Milne JD; Warnock DW
    Br J Vener Dis; 1977 Dec; 53(6):375-8. PubMed ID: 342069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some immunological properties of human cervical and vaginal secretions.
    Govers J; Girard JP
    Gynecol Invest; 1972; 3(5):184-94. PubMed ID: 4632685
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaginal eosinophils and IgE antibodies to Candida albicans in women with recurrent vaginitis.
    Witkin SS; Jeremias J; Ledger WJ
    J Med Vet Mycol; 1989; 27(1):57-8. PubMed ID: 2666634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin levels and antibody to Candida albicans in human cervicovaginal secretions.
    Waldman RH; Cruz JM; Rowe DS
    Clin Exp Immunol; 1972 Mar; 10(3):427-34. PubMed ID: 4556009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
    Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
    Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis.
    De Bernardis F; Boccanera M; Adriani D; Girolamo A; Cassone A
    Infect Immun; 2002 May; 70(5):2725-9. PubMed ID: 11953420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phagocytosis of Candida albicans by rabbit neutrophils.
    Venkataraman M; Mohapatra LN; Bhoyan UN
    Sabouraudia; 1973 Jul; 11(2):183-91. PubMed ID: 4584206
    [No Abstract]   [Full Text] [Related]  

  • 9. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.
    Sandini S; La Valle R; Deaglio S; Malavasi F; Cassone A; De Bernardis F
    FEMS Immunol Med Microbiol; 2011 Jul; 62(2):215-24. PubMed ID: 21535228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin type of anti-Candida albicans antibodies in candidal vaginitis.
    Segal E; Vardinon N; Foldes J
    Zentralbl Bakteriol Orig A; 1978 Nov; 242(2):265-7. PubMed ID: 367007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human natural yeast killer toxin-like candidacidal antibodies.
    Polonelli L; De Bernadis F; Conti S; Boccanera M; Magliani W; Gerloni M; Cantelli C; Cassone A
    J Immunol; 1996 Mar; 156(5):1880-5. PubMed ID: 8596040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological and pathological observations with Candida albicans-infected animals.
    Kuttin ES; Müller J; Douchet C; Vogt A
    Sabouraudia; 1983 Sep; 21(3):185-94. PubMed ID: 6356407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serodiagnostic value of extracellular antigens of an actively proteolysing culture of Candida albicans (immunodiffusion-test).
    Staib F; Mishra SK; Abel T
    Zentralbl Bakteriol Orig A; 1977 Jun; 238(2):284-7. PubMed ID: 407744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin classes of human serum antibodies in vaginal candidiasis.
    Warnock DW; Milne JD; Fielding AM
    Mycopathologia; 1978 Aug; 63(3):173-5. PubMed ID: 357978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [IgA, IgE and IgG subclasses to Candida albicans in serum and vaginal fluid from patients with vulvovaginal candidiasis].
    de Carvalho RJ; Cunha CM; Silva DA; Sopelete MC; Urzedo JE; Moreira TA; Moraes Pde S; Taketomi EA
    Rev Assoc Med Bras (1992); 2003; 49(4):434-8. PubMed ID: 14963598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis.
    De Bernardis F; Liu H; O'Mahony R; La Valle R; Bartollino S; Sandini S; Grant S; Brewis N; Tomlinson I; Basset RC; Holton J; Roitt IM; Cassone A
    J Infect Dis; 2007 Jan; 195(1):149-57. PubMed ID: 17152019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological cross reactivity between Candida albicans and human tissue.
    Vojdani A; Rahimian P; Kalhor H; Mordechai E
    J Clin Lab Immunol; 1996; 48(1):1-15. PubMed ID: 10332630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The quantitative immunochemical determination of Candida albicans-specific antibodies (author's transl)].
    Schwartze G; Friedrich E; Kühn G; Lübbe D
    Dermatol Monatsschr; 1979 Jan; 165(1):13-7. PubMed ID: 108142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specificity of the humoral immune response to Candida albicans in patients with panuveitis].
    Damms T; Böhnke M
    Fortschr Ophthalmol; 1989; 86(4):323-6. PubMed ID: 2676793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA and IgG serum antibodies to Candida albicans in women of child-bearing age.
    Schønheyder H; Johansen JA; Møller-Hansen C; Stenderup A
    Sabouraudia; 1983 Sep; 21(3):223-31. PubMed ID: 6356409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.